Main Category: Conferences
Article Date: 29 May 2012 - 2:00 PDT
Patient / Public:
Healthcare Prof:
Drugs discovered today can realistically cost upwards of 900 million dollars and around 12 years of development to reach a market. CRO's have been increasingly used by larger pharma to outsource their clinical research, allowing big pharma to shut down in-house RD, in practice saving money.
There have been some issues however with the outsourcing of trials to CROs, including serious relationship break down with negative attitudes, failure to communicate between to the partners and some claiming CROs do not 'get in the spirit' of the research following only the letter of the contract.
SMi's 4th annual Managing Partnerships with CROs will look to focus on 5 main areas: Optimising interaction between sponsors and CROs, Developing and executing strategic partnership models, Partner selection, Risk management and improving communication. It will provide delegates with a comprehensive overview and analysis of outsourcing in the pharmaceutical sector, offering the unique opportunity to hear from representatives from Pharma, CRO and Academia with an emphasis creating strong and successful partnerships between all parties.
Key benefits of attending:
- Learn from industry specialists what current issues are facing those working within sponsor CRO relationships.
- Understand what causes breakdown in relationships and ways to prevent this through real case studies.
- Hear from speakers on both sides of the relationship, and their strategies for developing successful partnership.
- Discuss the strategic rationale for clinical development outsourcing among the large pharmaceutical companies
Quote MNT and save £300
For more information visit http://www.smi-online.co.uk/goto/pharmaoutsourcingevent27.asp alternatively contact Fateja Begum on +44 0 207 827 6184 or email fbegum (at) smi-online.co.uk
MLA
APA
Please note: If no author information is provided, the source is cited instead.
Add Your Opinion On This Article
'Managing Partnerships With CROs 2012, 3-4 October'Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.
Privacy Policy | Terms and Conditions
MediLexicon International Ltd
Bexhill-on-Sea, United Kingdom
MediLexicon International Ltd © 2004-2012 All rights reserved.
MNT (logo) is the registered EU trade mark of MediLexicon Int. Limited.
Bexhill-on-Sea, United Kingdom
MediLexicon International Ltd © 2004-2012 All rights reserved.
MNT (logo) is the registered EU trade mark of MediLexicon Int. Limited.
Tidak ada komentar:
Posting Komentar